Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
NMDA receptors (NMDARs) are glutamate‐gated ion channels that play key roles in synaptic transmission and plasticity. Both hyper‐ and hypo‐activation of NMDARs are deleterious to neuronal function. In particular, NMDAR hypofunction is involved in a wide range of neurological and psychiatric conditions like schizophrenia, intellectual disability, age‐dependent cognitive decline, or Alzheimer's disease. While early medicinal chemistry efforts were mostly focused on the development of NMDAR antagonists, the last 10 years have seen a boom in the development of NMDAR positive allosteric modulators (PAMs). Here we review the currently developed NMDAR PAMs, their pharmacological profiles and mechanisms of action, as well as their physiological effects in healthy animals and animal models of NMDAR hypofunction. In light of the complexity of physiological outcomes of NMDAR PAMs in vivo , we discuss the remaining challenges and questions that need to be addressed to better grasp and predict the therapeutic potential of NMDAR positive allosteric modulation. image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568 · cited 5×
“Finally, NMDARs are also characterized by their particularly high permeability to calcium, which makes them major actors in synaptic plasticity, a phenomenon considered to be a key cellular substrate for learning and memory (Traynelis et al. 2010; Paoletti et al. 2013).”
BackgroundInfluentialMonyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 4×
“In the forebrain, GluN2D subunits are selectively expressed in interneurons (Monyer et al. 1994; Martina et al. 2013; Swanger et al. 2018; Garst-Orozco et al. 2020; Yi et al. 2020), suggesting a therapeutic potential of CIQ in diseases linked to NMDAR hypofunction and inhibitory transmission deficiency such as schizop…”
BackgroundInfluentialAnti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523 · cited 13×
“Finally, NMDARs are also characterized by their particularly high permeability to calcium, which makes them major actors in synaptic plasticity, a phenomenon considered to be a key cellular substrate for learning and memory (Traynelis et al. 2010; Paoletti et al. 2013).”
BackgroundInfluentialSelf-citationSynaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · cited 1×
“such as glycine, d-serine or d-cycloserine, or of glycine transporter 1 (GlyT1) inhibitors, such as sarcosine or Bitopertin, gave conflicting results, with overall no significant improvement of the negative and cognitive symptoms (Buchanan et al. 2007; Moghaddam & Javitt, 2012; Chang et al. 2019; Girgis et al. 2019).”
BackgroundThe molecular and cellular biology of enhanced cognition
Lee, Y.-S., & Silva, A. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2572 · Cited by 361
Cholesterol 24-Hydroxylase: an enzyme of cholesterol turnover in the brain
Russell, D. W., Halford, R. W., Ramirez, D. M. O., Shah, R., & Kotti, T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.072407.103859 · Cited by 317 · cited 1×
“Early evidence for a pro-cognitive action of 24(S)-HC, a pan-NMDAR PAM, came from the fact that mice lacking the cholesterol 24-hydroxylase enzyme, which converts cholesterol into 24(S)-HC (CYP46A1 KO mice), showed severe learning deficiencies, as well as impaired LTP at CA3-CA1 synapses (Kotti et al. 2006, 2008; Russ…”
BackgroundPerszyk, R. E., DiRaddo, J. O., Strong, K. L., Low, C.-M., Ogden, K. K., Khatri, A., Vargish, G. A., Pelkey, K. A., Tricoire, L., Liotta, D. C., et al. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105130 · Cited by 116
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
L-serine treatment in patients with GRIN -related encephalopathy: a phase 2A, non-randomized study
Juliá-Palacios, N., Olivella, M., Sigatullina Bondarenko, M., Ibáñez-Micó, S., Muñoz-Cabello, B., Alonso-Luengo, O., Soto-Insuga, V., García-Navas, D., Cuesta-Herraiz, L., Andreo-Lillo, P., et al. (2024) · Brain · doi:10.1093/brain/awae041 · Cited by 36
Deutsch, S. I., Luyo, Z. N. M., & Burket, J. A. (2022) · Biomolecules · doi:10.3390/biom12020181 · Cited by 22
“Interestingly, the 11.2 position on the short arm of chromosome 16 contains genes implicated in abnormalities of cortical development (e.g., MAPK3, KCTD13, and TAOK2).”
BackgroundMethodInfluentialDonello, J. E., McIntyre, R. S., Pickel, D. B., & Stahl, S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18020157 · Cited by 15
“Other NMDAR antagonists are allosteric modulators that bind noncompetitively at NMDAR sites other than the orthosteric ligand-binding domain, often in the NTD, and modulate NMDAR activity by altering the receptor’s sensitivity to its agonists [19,20,48].”
Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light
Geoffroy, C., Berraud-Pache, R., Chéron, N., McCort-Tranchepain, I., Doria, J., Paoletti, P., & Mony, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00247 · Cited by 9
Self-citation
Metadata
- Authors
- Geoffroy, C., Paoletti, P., & Mony, L.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2021-08-17
- Volume
- 600
- Issue
- 2
- Pages
- 233-259
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W3190309334
- Cited by
- 74
- References
- 14
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.